Literature DB >> 14562132

Prevalence and risk factors for erectile dysfunction in primary care: results of a Korean study.

B L Cho1, Y S Kim, Y S Choi, M H Hong, H G Seo, S Y Lee, H C Shin, C H Kim, Y S Moon, H S Cha, B S Kim.   

Abstract

In order to assess the prevalence and associated factors for erectile dysfunction (ED) in primary care, a cross-sectional study was undertaken by questionnaire distributed to consecutive adult male attendees at 32 family practices. ED was assessed by the Korean five-item version of the International Index of Erectile Function (IIEF-5). In total, 3501 completed questionnaires were available for analysis. The prevalence of ED was severe (IIEF-5 score: 5-9) in 1.6% of cases, moderate (10-13) in 10.2%, mild (14-17) in 24.7%, and normal (18-25) in 63.4%. The prevalence of ED increased with age, lower educational status, heavy job-related physical activity, and lower income. ED prevalence was significantly higher in patients with chronic diseases such as diabetes, depression, and anxiety. These results suggest that the age-adjusted prevalence of ED among Korean men can be estimated as 32.2% (95% CI 30.6-33.7). Low socioeconomic status and several diseases such as diabetes, anxiety, and depression, as well as age, were associated with ED.

Entities:  

Mesh:

Year:  2003        PMID: 14562132     DOI: 10.1038/sj.ijir.3901022

Source DB:  PubMed          Journal:  Int J Impot Res        ISSN: 0955-9930            Impact factor:   2.896


  17 in total

Review 1.  Male sexual dysfunction in Asia.

Authors:  Christopher Ck Ho; Praveen Singam; Goh Eng Hong; Zulkifli Md Zainuddin
Journal:  Asian J Androl       Date:  2011-06-06       Impact factor: 3.285

2.  The prescribing and dispensing of phosphodiesterase type 5 inhibitors in South Korea: a questionnaire survey of patient discomfort.

Authors:  Sang Woo Kim; Jong Wook Kim; Ji Yun Chae; Jin Wook Kim; Cheol Yong Yoon; Mi Mi Oh; Hong Seok Park; Je Jong Kim; Du Geon Moon
Journal:  World J Mens Health       Date:  2014-08-26       Impact factor: 5.400

3.  Cross-cultural validation of Irritable Bowel Syndrome Quality of Life in Korea.

Authors:  Jae M Park; Myung-Gyu Choi; Jung Hwan Oh; Yu Kyung Cho; In Seok Lee; Sang Woo Kim; Kyu Yong Choi; In-Sik Chung
Journal:  Dig Dis Sci       Date:  2006-07-20       Impact factor: 3.199

Review 4.  Prevalence and medical management of erectile dysfunction in Asia.

Authors:  Kwangsung Park; Eu Chang Hwang; Sun-Ouck Kim
Journal:  Asian J Androl       Date:  2011-04-04       Impact factor: 3.285

5.  Erectile Dysfunction among Yemenis: Does Chewing Khat Play a Role?

Authors:  Omar H Nassar; Hameed M Aklan
Journal:  Eurasian J Med       Date:  2014-06

6.  The SUBITO-DE study: sexual dysfunction in newly diagnosed type 2 diabetes male patients.

Authors:  G Corona; C B Giorda; D Cucinotta; P Guida; E Nada
Journal:  J Endocrinol Invest       Date:  2013-05-20       Impact factor: 4.256

Review 7.  Korean Society for Sexual Medicine and Andrology (KSSMA) Guideline on Erectile Dysfunction.

Authors:  Ji Kan Ryu; Kang Su Cho; Su Jin Kim; Kyung Jin Oh; Sung Chul Kam; Kyung Keun Seo; Hong Seok Shin; Soo Woong Kim
Journal:  World J Mens Health       Date:  2013-08-31       Impact factor: 5.400

8.  Lower urinary tract symptoms and erectile dysfunction in men with type 2 diabetes mellitus.

Authors:  Hyo Jeong Song; Eun Joo Lee; Nancy Bergstrom; Duck-Hee Kang; Dae Ho Lee; Gwangpyo Koh; Jung-Sik Huh; Sung Dae Kim; Seong Cheol Hong; Seong Sil Moon; Jiyoung Kang
Journal:  Int Neurourol J       Date:  2013-12-31       Impact factor: 2.835

9.  Prevalence and correlates of erectile dysfunction among primary care clinic attendees in Nigeria.

Authors:  Lawrence Adekunle Adebusoye; Olubunmi E Olapade-Olaopa; Modupe M Ladipo; Eme T Owoaje
Journal:  Glob J Health Sci       Date:  2012-06-08

10.  Erectile dysfunction in patients with liver disease related to chronic hepatitis B.

Authors:  Min Kim; Seul Young Kim; Woo Sun Rou; Se Woong Hwang; Byung Seok Lee
Journal:  Clin Mol Hepatol       Date:  2015-12-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.